Lilly's weight-loss medications Mounjaro and Zepbound are gaining market share on Novo's Wegovy and Ozempic, but investors ...

Elanco Animal Health Incorporated (NYSE:ELAN) reported second-quarter 2025 results on Thursday, posting adjusted earnings per ...

Disney's Q3 2025 results were nothing to be excited about, and the market reacted accordingly. Click here to find out why DIS ...

On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns ...

Figma and stablecoin giant Circle peaked at 333 per cent and 864 per cent above their IPO prices in the days following their ...

“Younger generations are more plugged into the fast-moving pace of markets, where volatility can spike in a matter of minutes ...

Glean insights from Berkshire Hathaway Inc.'s Q2 results, including insurance losses, core growth drivers, and Warren Buffett ...